{"title":"Determinants of Topical 5-Aminosalicylic Acid Use inVeterans with Ulcerative Colitis","authors":"R. Shah, J. Hou, H. Malaty, S. Sansgiry","doi":"10.4172/2472-1891.100005","DOIUrl":null,"url":null,"abstract":"Aims: The aim of our study was to identify the determinants of topical 5-ASA therapy in a large ulcerative colitis cohort. \nMethods: We performed a cross sectional study of patients receiving care through the Veterans Administration (VA) from 2003 to 2009. Patients with UC were identified using ICD-9 codes. Patient demographic and prescription data were obtained from national VA datasets. Univariate and multivariate logistic regression were used to identify the effect of age, gender and race on topical 5-ASA therapy use. \nResults: We identified 20,259 UC patients for inclusion in the analysis. The prevalence of topical 5-ASA therapy use was 27%. With univariate logistic regression, female gender and non-Caucasian race were associated with a higher odds of topical 5-ASA therapy use. Increasing age was associated with lower odds of topical 5-ASA therapy use. On multivariate logistic regression, Blacks and Hispanics remained more likely to use topical 5-ASA therapies compared to Caucasians and increasing age remained associated with a lower odds of topical 5-ASA therapy; however, other demographic features lost significance. \nConclusions: In a large, national cohort of patients with UC, Blacks and Hispanics were more likely to use topical 5-ASA therapies compared to patients of other ethnicities.","PeriodicalId":355284,"journal":{"name":"International Journal of Digestive Diseases","volume":"7 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Digestive Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2472-1891.100005","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Aims: The aim of our study was to identify the determinants of topical 5-ASA therapy in a large ulcerative colitis cohort.
Methods: We performed a cross sectional study of patients receiving care through the Veterans Administration (VA) from 2003 to 2009. Patients with UC were identified using ICD-9 codes. Patient demographic and prescription data were obtained from national VA datasets. Univariate and multivariate logistic regression were used to identify the effect of age, gender and race on topical 5-ASA therapy use.
Results: We identified 20,259 UC patients for inclusion in the analysis. The prevalence of topical 5-ASA therapy use was 27%. With univariate logistic regression, female gender and non-Caucasian race were associated with a higher odds of topical 5-ASA therapy use. Increasing age was associated with lower odds of topical 5-ASA therapy use. On multivariate logistic regression, Blacks and Hispanics remained more likely to use topical 5-ASA therapies compared to Caucasians and increasing age remained associated with a lower odds of topical 5-ASA therapy; however, other demographic features lost significance.
Conclusions: In a large, national cohort of patients with UC, Blacks and Hispanics were more likely to use topical 5-ASA therapies compared to patients of other ethnicities.